Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 8

1.

Survival in women with ovarian cancer before and after the introduction of adjuvant paclitaxel; a 25-year, single institution review.

Shireen R, Brennan D, Flannelly G, Fennelly D, Lenehan P, Foley M.

Ir Med J. 2012 Feb;105(2):47-50.

PMID:
22455239
[PubMed - indexed for MEDLINE]
2.

A systematic overview of chemotherapy effects in ovarian cancer.

Högberg T, Glimelius B, Nygren P; SBU-group. Swedish Council of Technology Assessment in Health Care.

Acta Oncol. 2001;40(2-3):340-60. Review.

PMID:
11441940
[PubMed - indexed for MEDLINE]
3.

Gynecological malignancies.

Schaebler DL, Schilder RJ, Young RC.

Cancer Chemother Biol Response Modif. 1996;16:564-91. Review.

PMID:
8639401
[PubMed - indexed for MEDLINE]
4.

Medical therapy of advanced malignant epithelial tumours of the ovary.

Colombo N, Parma G, Bocciolone L, Franchi D, Sideri M, Maggioni A.

Forum (Genova). 2000 Oct-Dec;10(4):323-32. Review.

PMID:
11535983
[PubMed - indexed for MEDLINE]
5.

Progressive epithelial ovarian carcinoma. Prognostic factors and clinical management.

Grønlund B.

Dan Med Bull. 2006 Aug;53(3):232-57. Review. No abstract available.

PMID:
17092448
[PubMed - indexed for MEDLINE]
6.

Advanced ovarian cancer.

van der Burg ME.

Curr Treat Options Oncol. 2001 Apr;2(2):109-18. Review.

PMID:
12057129
[PubMed - indexed for MEDLINE]
7.

Chemotherapy in advanced ovarian carcinoma: current standards of care based on randomized trials.

Thigpen T, Vance R, Puneky L, Khansur T.

Gynecol Oncol. 1994 Dec;55(3 Pt 2):S97-107. Review.

PMID:
7835816
[PubMed - indexed for MEDLINE]
8.

Mucinous tumours of the ovary.

Naik JD, Seligmann J, Perren TJ.

J Clin Pathol. 2012 Jul;65(7):580-4. doi: 10.1136/jclinpath-2011-200320. Epub 2011 Oct 19. Review.

PMID:
22011449
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk